ISPH fundamentals
An in-depth look to IBNSINA PHARMA operating, investing, and financing activities
ISPH free cash flow for Q2 24 is 183.58 M EGP. For 2023, ISPH free cash flow was -228.23 M EGP and operating cash flow was 125.81 M EGP.
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EGP
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM